Global Cannabis Applications Corp (GCAC) (CSE:APP, FRA:2FA, OTCQB:FUAPF), a leading developer of innovative smartphone applications for the cannabis industry, announces it has entered into discussions with respect to medical cannabis technology applications including Artificial Intelligence (“AI”), data scraping and Blockchain delivery with a leading Australian technology accelerator and aggregator, Fintechgration.
In September 2017, GCAC intends to commence trials on a proprietary AI regulatory monitoring platform to manage international ISO standards for medical cannabis.  The data collected from this technology is anticipated to augment the existing data pool used within GCAC’s Citizen Green App suite and proprietary ‘Pain to Strain’ database.
AI compliance technology proposes to help deliver a near bullet proof auditing system for regulatory compliance across global jurisdictions, and may have immediate application to ‘Schedule 8’ medical cannabis regulation in countries such as Australia.
Blockchain is a disruptive, secure, digital “distributed ledger” that is being heralded as a significant innovation that could have far reaching implications in health and financial industries.  The technology may be used to collect data from and improve medical cannabis supply chains.
These cutting-edge technologies coupled with Citizens Green’s “Pain to Strain’ database (built from over 10 years of field research tracking medicinal cannabis users seeking therapeutic remedies for multiple conditions including cancer and epilepsy), have the potential to generate significant improvements on data insights for ongoing clinical trials in the medical cannabis arena.
“This is an exciting new frontier.  GCAC eagerly anticipates exploring AI along with the application of Blockchain technology fed by dynamic social media to provide the basis for curating authoritative data for medical practitioners, researchers, providers and growers,” says Jason Webb, Managing Director of GCAC, Australia.
GCAC’s business is focused on ‘big data’, which will be aggregated through various technologies enabling users, patients, doctors, pharmacists, providers and practitioners to more easily identify key strains of cannabis that have the greatest benefit to targeted ailments for personal well being.  
States GCAC CEO, Brad Moore, “Our innovative approach to technology in the medical cannabis space alongside the rich data experience derived from our Citizen Green Apps will build the foundational blocks for understanding and participating in the growing world of medical cannabis.”
About Global Cannabis Applications Corp.
Global Cannabis is a global leader in designing, developing, marketing, and acquiring innovative mobile applications.  Used in over 25 countries, GCAC’s apps facilitate the proliferation of digital conversations by like-minded people.  Managed by digital industry experts, GCAC is focused on viral global expansion by providing the best user experience in each target market.  Its leading mobile platforms are Citizen Green, a family of apps dedicated to the digital world of all things cannabis; Foro, a peer-to-peer mobile ecommerce student marketplace; Opinit, an app that enables users to socially share their favourite online sentiment-driven content; and Truth, a one-to-one anonymous messaging app.
For more information about the Company, please visit online at www.cannappscorp.com, or review its profiles on the SEDAR website (www.sedar.com) and on the Canadian Securities Exchange’s website (www.thecse.com)
 
To schedule an interview, please contact:
Bradley Moore
Chief Executive Officer
Telephone:  514-561-9091
Email: bmoore@cannappscorp.com
For more information, please contact:
Corporate Communications
Telephone: 1.855.269.9554
Email: info@cannappscorp.com
www.cannappscorp.com
 
Forward-Looking Information
This news release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of GCAC.  Forward-looking information is based on certain key expectations and assumptions made by the management of GCAC.  Although management of the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because GCAC can give no assurance that they will prove to be correct.  Forward-looking statements contained in this news release are made as of the date of this news release.  GCAC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy and accuracy of this information. 
Click here to connect with Global Cannabis Applications Corp (GCAC) (CSE:APP, FRA:2FA, OTCQB:FUAPF)) to receive an Investor Kit.

Source: www.benzinga.com


CanBud Distribution Corporation (CSE: CBDX) (FSE: CD0) (“CanBud” or the “Corporation”) is pleased to announce that it has closed the final tranche of its oversubscribed non-brokered private placement for aggregate gross proceeds of approximately $4,730,000 (the “Offering”).

The Corporation issued a combined total of 39,409,346 units (each a “Unit“) at price of $0.12 per Unit, with each Unit comprised of one common share in the capital of the Corporation (each a “Common Share“) and one common share purchase warrant (each a “Warrant“). Each Warrant entitles the holder to purchase one additional Common Share at an exercise price of $0.22 within 24 months of the closing of the Offering (the “Warrant Term“), provided, however that if the closing price of the Common Shares on the Canadian Securities Exchange (the “CSE“) (or any such other stock exchange in Canada as the Common Shares may trade at the applicable time) is $0.25 or greater per Common Share for a period of five (5) consecutive trading days at any time after the closing date of the Offering, the Corporation may accelerate the Warrant Term such that the Warrants shall expire on the date which is 30 days following the date a press release is issued by the Corporation announcing the reduced warrant terms.

Keep reading... Show less

Thoughtful Brands Inc. (CSE:TBI)(FSE:1WZ1)(OTCQB:PEMTF) (the “Company” or “Thoughtful Brands) announces that the letter of intent with Franchise Cannabis Corp. (“FCC”), previously announced in January, has been terminated. The previously announced European joint venture with FCC will continue and allow the Company to launch and tailor its products to European consumer demands

In connection with termination of the merger transaction with FCC, the Company has agreed to pay FCC $100,000 in cash and to issue FCC 5,000,000 common shares of the Company at a deemed value of $0.05 per share. The common shares will be subject to a four-month-and-one-day statutory hold period in accordance with applicable securities laws.

Keep reading... Show less

Mergers and acquisitions (M&A) in cannabis space have helped boost the industry to new levels.

Keep reading... Show less

Strategic sale of non-core assets by Lobe adds non-dilutive capital and shareholder value

Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) is pleased to announce, further to its press release dated February 23, 2021, that it has completed the sale to Ionic Brands Corp. (“Ionic Brands”) of Lobe’s non-core cannabis assets relating to Washington-based Cowlitz County Cannabis Cultivation Inc. (“Cowlitz”) held by Lobe’s subsidiary vendor, Green Star Biosciences Inc. (the “Transaction”).

Keep reading... Show less

Adding to its existing presence on the west coast of the United States, all five KOIOS™ flavours and all four Fit Soda™ flavours will be carried in Metropolitan Market stores beginning on Monday, March 22, 2021. Serving the Seattle-Tacoma area (population 3.87 million), Metropolitan Market is one of five chains under its parent firm Good Food Holdings, which has a total of 51 stores in California, Oregon, and Washington State.

Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF) (the “Company” or “Koios”) is pleased to announce that beginning on Monday, March 22, 2021, Koios’ entire line of canned beverage products will be sold at all locations of Metropolitan Market, an urban format supermarket chain in the Seattle-Tacoma area of Washington State. In Q1 2021, the Company announced multiple placements of its beverage products with regional grocers in markets on the west coast of the United States including Market of Choice in Oregon Jensen’s in Southern California and major natural grocery chain Sprouts Farmers Market which has a substantial west coast presence with over one third of its locations (360+ stores across 23 states) in California as well as Washington State 1 . The Company has also recently announced other developments relating to its expansion efforts being undertaken in 2021 such as an in-house beverage canning facility and distribution agreements with regional and national wholesale partners.

Keep reading... Show less